Indication
Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia
Lymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia. Read more about Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia
46 drugs 38 manufacturers
Drugs that treat it
Common Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia therapies.
IMATINIB MESYLATE
IMATINIB MESYLATE
DASATINIB
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
DASATINIB
DASATINIB
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia.
Pathophysiologically driven by the reciprocal translocation producing the Philadelphia chromosome and BCR::ABL1 fusion oncoprotein, this state arises primarily in the bone marrow and peripheral blood, though extramedullary involvement can also occur.
It is clinically defined by an uncontrolled expansion of immature lymphoid precursor cells, typically manifesting with 20% or more lymphoblasts in the blood or marrow and mimicking acute lymphoblastic leukemia.
This phase leads to profound bone marrow failure characterized by progressive cytopenias, splenomegaly, systemic B-symptoms, and increased vulnerability to severe infection and bleeding.
- nih.gov
Lymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia Pathophysiologically driven by the reciprocal translocation producing the Philadelphia chromosome and BCR::ABL1 fusion oncoprotein, this state arises primarily in the bone marrow and peripheral blood, though extramedullary involvement can also occur This phase leads to profound bone marro...
- cancer.gov
Lymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia
- incitefulmed.com
Pathophysiologically driven by the reciprocal translocation producing the Philadelphia chromosome and BCR::ABL1 fusion oncoprotein, this state arises primarily in the bone marrow and peripheral blood, though extramedullary involvement can also occur
- cancer.org
Pathophysiologically driven by the reciprocal translocation producing the Philadelphia chromosome and BCR::ABL1 fusion oncoprotein, this state arises primarily in the bone marrow and peripheral blood, though extramedullary involvement can also occur It is clinically defined by an uncontrolled expansion of immature lymphoid precursor cells, typically manifesting with 20% or more lymphoblasts in the blood or marrow and mimicking acute lymphoblastic leukemia This phase leads to profound bone marrow...
- cpho.or.kr
It is clinically defined by an uncontrolled expansion of immature lymphoid precursor cells, typically manifesting with 20% or more lymphoblasts in the blood or marrow and mimicking acute lymphoblastic leukemia
Personalize your experience
Follow Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.